Child and Adolescent Immunization Schedule, 2022
Recommendations for Ages 18 Years or Younger, United States, 2022
¶ = Range of recommended ages for all children
†= Range of recommended ages for catch-up immunization
§ = Range of recommended ages for certain high-risk groups
# = Recommended vaccination can begin in this age group
± = Recommended vaccination based on shared clinical decision-making
• = No recommendation/Not applicable
Birth to 15 Months
| Vaccine | Birth | 1 mo | 2 mos | 4 mos | 6 mos | 9 mos | 12 mos | 15 mos |
|---|---|---|---|---|---|---|---|---|
Hepatitis B  (HepB) |
1st dose¶ | ←2nd dose→¶ | † | ←3rd dose→¶ | ||||
| Rotavirus (RV) RV1 (2-dose series); RV5 (3-dose series) |
• | • | 1st dose¶ | 2nd dose¶ | See notes¶ | • | • | • |
| Diphtheria, tetanus, & acellular pertussis (DTaP: <7 yrs) |
• | • | 1st dose¶ | 2nd dose¶ | 3rd dose¶ | † | ←4th dose→¶ | |
| Haemophilus influenzae type b (Hib) |
• | • | 1st dose¶ | 2nd dose¶ | See notes¶ | † | ←3rd or 4th dose, See notes→¶ |
|
| Pneumococcal conjugate (PCV13) |
• | • | 1st dose¶ | 2nd dose¶ | 3rd dose¶ | † | ←4th dose→¶ | |
| Inactivated poliovirus (IPV: <18 yrs) |
• | • | 1st dose¶ | 2nd dose¶ | ←3rd dose→¶ | |||
| Influenza (IIV4) |
• | • | • | • | Annual vaccination 1 or 2 doses¶ | |||
 Influenza (LAIV4) |
• | • | • | • | • | • | • | • |
| Measles, mumps, rubella (MMR) |
• | • | • | • | See notes§ | ←1st dose→¶ | ||
| Varicella (VAR) |
• | • | • | • | • | • | ←1st dose→¶ | |
| Hepatitis A (HepA) |
• | • | • | • | See notes§ | ←2-dose series, See notes→¶ | ||
| Tetanus, diphtheria, & acellular pertussis (Tdap: ≥7 yrs) |
• | • | • | • | • | • | • | • |
| Human papillomavirus (HPV) |
• | • | • | • | • | • | • | • |
| Meningococcal (MenACWY-D ≥9 mos, MenACWY-CRM ≥2 mos, MenACWY-TT ≥2years) |
• | • | See notes§ | |||||
| Meningococcal B (MenB-4C, MenB-FHbp) |
• | • | • | • | • | • | • | • |
| Pneumococcal polysaccharide (PPSV23) |
• | • | • | • | • | • | • | • |
| Dengue (DEN4CYD; 9-16 yrs) |
• | • | • | • | • | • | • | • |
18 Months to 18 Years
| Vaccines | 18 mos | 19-23 mos | 2-3 yrs | 4-6 yrs | 7-10 yrs | 11-12 yrs | 13-15 yrs | 16 yrs | 17-18 yrs | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hepatitis B (HepB) |
←3rd dose→¶ | † | |||||||||||
| Rotavirus (RV) RV1 (2-dose series); RV5 (3-dose series) |
• | • | • | • | • | • | • | • | • | ||||
| Diphtheria, tetanus, & acellular pertussis (DTaP: <7 yrs) |
←4th dose→¶ | † | † | 5th dose¶ | • | • | • | • | • | ||||
| Haemophilus influenzae type b (Hib) |
† | § | |||||||||||
| Pneumococcal conjugate (PCV13) |
† | § | |||||||||||
| Inactivated poliovirus (IPV: <18 yrs) |
←3rd dose→¶ | † | 4th dose¶ | † | † | • | |||||||
| Influenza (IIV4) |
Annual vaccination 1 or 2 doses¶ | ¶ | Annual vaccination 1 dose only¶ | ||||||||||
Influenza (LAIV4) |
• | • | Annual vaccination 1 or 2 doses¶ |
Annual vaccination 1 dose only¶ | |||||||||
| Measles, mumps, rubella (MMR) |
† | 2nd dose¶ | † | ||||||||||
| Varicella (VAR) |
† | 2nd dose¶ | † | ||||||||||
| Hepatitis A (HepA) |
← 2-dose series, See notes→¶ | † | |||||||||||
| Tetanus, diphtheria, & acellular pertussis (Tdap: ≥7 yrs) |
• | • | • | • | † | 1 dose¶ | § | ||||||
| † | |||||||||||||
| Human papillomavirus (HPV) |
• | • | • | • | • | § | See notes¶ | † | |||||
| # | |||||||||||||
| Meningococcal (MenACWY-D ≥9 mos, MenACWY-CRM ≥2 mos, MenACWY-TT ≥2years) |
See notes§ | 1st dose¶ | † | 2nd dose¶ | † | ||||||||
| Meningococcal B (MenB-4C, MenB-FHbp) |
• | • | • | • | • | § | See notes§ | ||||||
| • | • | • | ± | ||||||||||
| Pneumococcal polysaccharide (PPSV23) |
• | • | See notes§ | ||||||||||
| Dengue (DEN4CYD; 9-16 yrs) |
• | • | • | • | • | Seropositive in endemic areas only (See notes)¶ |
• | ||||||